Blog
    Peptide SpotlightFor PatientsSeptember 30, 2026

    Ipamorelin vs Sermorelin: How Do These Two Compare?

    Compare Ipamorelin and Sermorelin to see how they affect growth hormone. Learn about their research history, safety grades, and what scientists actually know.

    Ipamorelin vs Sermorelin: A Fair Fight

    If you have been looking into peptides, you have probably seen these two names pop up a lot. Both are designed to tell your body to release more growth hormone, but they go about it in slightly different ways.

    Think of your body like a factory. These compounds are like different managers giving orders to the production line. Here is the breakdown of how they work and what the actual data says.

    What is the difference in how they work?

    Sermorelin is what scientists call a GHRH analog. That is just a fancy way of saying it acts like the natural signal your brain sends to your pituitary gland—the pea-sized organ at the base of your brain—to release growth hormone.

    It is pretty polite to your body because it respects your natural feedback loops. This means it helps keep your hormone levels from getting too high. It was actually the first compound used as a reference standard for this type of therapy.

    Ipamorelin works differently. It is a selective ghrelin receptor agonist. Basically, it mimics a different hormone to trigger short, quick bursts of growth hormone that last about two hours.

    One interesting thing about Ipamorelin is its precision. It was the first compound found to be truly selective, meaning it triggers growth hormone without messing with other things like cortisol—your stress hormone—or prolactin.

    Which one has more evidence behind it?

    If we are looking at the history books, Sermorelin has a bit more of a track record. It earned an evidence grade of B+ on our platform.

    • Sermorelin was actually FDA-approved back in the 90s for kids who weren't growing enough.
    • It also has two completed clinical trials showing positive results for brain health and thinking skills.
    • It was eventually pulled from the market in 2008, but the company said that was because of supply issues, not because it was unsafe.

    Ipamorelin has an evidence grade of B-. Scientists are still figuring this one out.

    • It finished Phase II trials for stomach-related issues, but it didn't meet the goals the researchers were looking for.
    • While it is good at triggering growth hormone, there are actually no published clinical trials showing it helps with body shape, fat loss, or gym performance.

    What are the missing pieces?

    Scientists are still working on these—turns out the human body is complicated. Who knew?

    For Sermorelin, we are missing large-scale studies in adults. One study on aging only had 19 people in it, which is a very small group. Because the original maker stopped producing it, no one is currently paying for the big studies needed to prove it works for adult aging.

    For Ipamorelin, there are some safety flags. The FDA has mentioned concerns about how it is made in compounding pharmacies. Also, if you are a professional athlete, you should know that WADA—the group that keeps sports fair—has banned it.

    One big thing to note: many people talk about mixing Ipamorelin with CJC-1295. However, there is currently zero clinical trial evidence for that specific combination.

    Moving forward

    This is a great one to bring up with your doctor. You can find peptide-experienced physicians in our directory who can help you look at your specific health needs.

    If you want to dive deeper into the specifics of each one, you can check out our full guides for sermorelin and ipamorelin. Finding a qualified peptide doctor is the best way to navigate these options safely.

    This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.

    Referenced Peptides

    This content was generated from TruthTides clinical reference data. It does not constitute medical advice. Always consult a qualified healthcare provider.